Clinical Trial on Application of Injectable Recombinant Human Luteinizing Hormone (Luveris) in the Treatment of Chinese Female Patients With Hypogonadotropic Hypogonadism: A Multi-center, Open, Prospective Drug Clinical Trial for Registration

Trial Profile

Clinical Trial on Application of Injectable Recombinant Human Luteinizing Hormone (Luveris) in the Treatment of Chinese Female Patients With Hypogonadotropic Hypogonadism: A Multi-center, Open, Prospective Drug Clinical Trial for Registration

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Lutropin alfa (Primary) ; Chorionic gonadotropin; Follitropin alfa
  • Indications Female infertility
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Sponsors Merck KGaA
  • Most Recent Events

    • 22 May 2012 Official Title amended as reported by ClinicalTrials.gov.
    • 22 May 2012 Actual end date changed from Feb 2005 to Dec 2005 as reported by ClinicalTrials.gov.
    • 22 May 2012 Actual initiation date changed from Jun 2004 to Feb 2004 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top